According to a recent SEC filing, enterprise IT startup Intervention Insights raised $4.2 million in financing from an undisclosed investor. Intervention Insights, located in Waltham, Massachusetts, is a health information services company that helps community oncologists incorporate molecular oncology into their practice. The company enables oncology
Artificial intelligence startup PathAI announced the completion of $11 million in Series A financing led by General Catalyst Partners, with participation from Refactor Capital, 8VC, Danhua Capital, KdT Ventures, and Pillar. PathAI’s intelligent pathology platform provides end-to-end, data-driven pathology analysis, resulting in fast, accurate, and standardized
Artoss closed a new round of funding from angelMD. The company’s scientists apply their knowledge of physics and biology to create new nanostructured biomaterials for bone repair. Artoss currently distributes NanoBone® advanced bone graft products in the United States, while NanoBone Granules and NanoBone SBX Putty
Single-cell DNA analysis company Mission Bio, Inc. announced it has secured $10 million in Series A funding led by Mayfield Fund. Mission Bio’s Tapestri platform is a scalable, highly sensitive, and customizable precision genomics platform that addresses current industry shortcomings with throughput up to 10,000
According to a recent SEC filing, software startup ESO Solutions has raised $15.5 million in financing from an undisclosed investor. ESO delivers healthcare interoperability, software applications and data management to the pre-hospital and hospital healthcare market. ESO's first-of-its-kind interoperability solution, Health Data Exchange, connects pre-hospital healthcare
Cardiologs Technologies announced today that it has raised $6.4 million in a Series A financing from new investors Idinvest, ISAI, Kurma Partners, and Partech Ventures, as well as current investor Bpifrance seed fund (F3A). In July, 2017, Cardiologs announced FDA clearance of its Cardiologs ECG
CareCloud has created a new patient experience platform, Breeze, that helps doctors make their practices more modern and efficient. It facilitates the many different interactions a patient has with medical practices, from making appointments to checking in, providing health histories and insurance information, and managing
Humacyte, an innovator in biotechnology and regenerative medicine, announced today that the company has received a Broad Agency Announcement (BAA) contract award of $3.4 million from the U.S. Department of Defense (DoD). The funding will help support the addition of clinical sites for Humacyte’s Phase
According to a recent SEC filing, software startup ePatientFinder has raised $2.6 million in financing from an undisclosed investor. ePatientFinder uses analytics technology to connect patients with cutting-edge treatments recently approved by the FDA or still in clinical trials. ePatientFinder has a network of primary care
Tempus announced the completion of $130 million in Series C financing led by New Enterprise Associates and Revolution Growth. Tempus is a technology company that is building the world’s largest library of molecular and clinical data and an operating system to make that data accessible and